Researchers at the University of Texas at Austin have developed an electroencephalogram (EEG) sensor that is incorporated into a virtual reality headset....
The Advanced Research Projects Agency for Health (ARPA-H) has awarded $45 million to rapidly develop sense-and-respond implant technology that could slash...
The Dales Report is here with another Psychedelic Exclusive podcast. Today, Shadd and Anthony sit down with analyst Elmer Piros to talk about the investment...
HOUSTON – (Sept. 26, 2023) – The Advanced Research Projects Agency for Health (ARPA-H) has awarded $45 million to rapidly develop sense-and-respond...
Ionis is another step closer to the launch of its first independent drug, touting positive Phase III data for olezarsen in patients with a rare genetic...
On September 25, 2023, Vaccitech (NASDAQ: VACC) experienced a jaw-dropping 90% surge in its stock price in just one day of trading. Now, this kind of...
By not disclosing milestone dollars that may or may never materialize, Exelixis showed Insilico Medicine CEO Alex Zhavoronkov, PhD, that its PR folks were...
To learn more about what causes the body to reject biomedical implants, a team at the University of Arizona College of Medicine – Tucson identified...
PLYMOUTH MEETING, PA [September 25, 2023] —Evelyn Handel Zapata, PharmD, BCPS, BCOP, Senior Director of Drugs & Biologics Programs at the National...
Jennifer Meade, Aldevron’s new president, has been elevated from general manager, nucleic acids, where she led strategic initiatives that included expanding...
The Dales Report is here with another Psychedelic Exclusive podcast. Today, Shadd and Anthony sit down with analyst Elmer Puro to talk about the investment...
MIAMI, FLORIDA (Sept. 22, 2023) – Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine found an...
“We have summarized some of our findings regarding the response of various subsets of CRC to kinase inhibitors […].” Credit: Patricia M. Gomez Barila...
Dana-Farber Cancer Institute announced on Sept. 14 that it is securing a new joint venture with Beth Israel Deaconess Medical Center, marking a breakup...
Cybin Inc. CYBN has completed enrollment in its Phase 2 study of novel deuterated psilocybin analog CYB003 for the potential treatment of Major Depressive...
Mark Velleca → David M. Epstein is out as CEO of cancer player Black Diamond Therapeutics, which is putting chairman Mark Velleca in charge. This is...
America's First 'Shroom Clinic' Opens In Oregon America's first licensed health clinic to sell 'magic mushrooms' opened in June in Oregon...
An international clinical trial exploring a new way to treat rare and aggressive gynaecological cancers has launched in Melbourne. Credit: WEHI An international...
According to EY, the professional services firm originally known as Ernst & Young, biopharma M&A deals during the first six months of 2023 more...
Jura Bio has built an end-to-end discovery and development platform to develop immune-based therapeutics using machine learning and synthetic biology....
The Novo Nordisk Foundation revealed Thursday it has committed €127 million ($135.4 million) to build a new cell therapy facility in Denmark, which is...
September 21, 2023, NEW YORK – A Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with an innovative, personalized...
Credit: Laura M. Lombardía / CNIO. Elisabete Weiderpass, director of the International Agency for Research on Cancer (IARC), pointed out that half...
The No. 1 cause of death in children is trauma. There are an estimated 2,000 pediatric deaths from traumatic bleeding in the U.S. each year that...
Jigang Wang et al. have made significant progress in unraveling the antimalarial mechanisms of artemisinin (ART) and its derivatives. Their latest research,...
Democrat Reps. Robert Garcia and Earl Blumenauer filed a new bill in Congress that would discourage federal law enforcement and general intervention in...
Every year, without fail, the Endpoints 11 proves to be the most challenging project I face — and definitely remains the most fun. In an industry...
By her own admission, Elizabeth Wood is far from a typical biotech CEO. Fittingly, she’s building an unconventional startup in JURA Bio, which announced...
(Memphis, Tenn.— Sept. 20, 2023) Hyperdiploidy is a genetic condition observed in cancer cells, where the cells contain more chromosomes than usual....
“[…] we demonstrated that DPP4 inhibition increased sunitinib efficacy in DPP4-high RCC spheroids and DPP4 was upregulated in sunitinib-resistant RCC...